China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real-world study of Adebrelimab in locally advanced or metastatic solid tumors'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135615
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: Huai Nan Xinhua Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345203
Published by HT Digital Content Services with permission from Health Daily Digest....